Regression of mesenchymal hamartoma of the liver with sarcoma chemotherapy.

Kuperman, Amir A; Kornreich, Liora; Feinmesser, Meora; Ash, Shifra; Yaniv, Issac; Cohen, Ian J

Kuperman, Amir A; Kornreich, Liora; Feinmesser, Meora; Ash, Shifra; Yaniv, Issac; Cohen, Ian J.

Affiliation

Kuperman AA; Pediatric Hematology and Blood Coagulation Service, Western Galilee Hospital, Naharia, Israel. amir.kuperman@naharia.health.gov.il

J Pediatr Hematol Oncol ; 35(1): e25-6, 2013 Jan.

Article in En | MEDLINE | ID: mdl-22935658

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Bone Neoplasms/diagnosis; Diagnostic Errors; Hamartoma/drug therapy; Liver Neoplasms/drug therapy; Mesoderm/pathology; Sarcoma, Ewing/diagnosis; Adult; Cyclophosphamide/administration & dosage; Dactinomycin/administration & dosage; Doxorubicin/administration & dosage; Etoposide/administration & dosage; Female; Hamartoma/pathology; Humans; Ifosfamide/administration & dosage; Liver Neoplasms/secondary; Prognosis; Vincristine/administration & dosage; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma, Ewing / Bone Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Diagnostic Errors / Hamartoma / Liver Neoplasms / Mesoderm Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Female / Humans Language: En Journal: J Pediatr Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2013 Type: Article Affiliation country: Israel

Fulltext

XML

PubMed Links

Search on Google